
Megmazid SB 1000mg/500mg Injection
Marketer
Ridhima Biocare
Salt Composition
Ceftazidime (1000mg) + Sulbactam (500mg)
Overview Megmazid SB 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus curbing infection spread. Administration must be strictly under a physician's guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, even with symptom improvement. Premature cessation may compromise its efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Seek emergency medical help for allergic responses (skin rashes, itching, swelling, respiratory distress). Inform your doctor of all current medications, including over-the-counter drugs, prior to commencement. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing drowsiness or dizziness. Adequate rest, nutritious diet, and hydration are recommended for optimal recovery. Monitoring treatment response may involve periodic laboratory tests as determined by your doctor.
Primary Ingredients of Megmazid SB 1000mg/500mg Injection
The provided text is "undefined," which cannot be rephrased while maintaining meaning and length. There is no original text to rewrite.
Uses of Megmazid SB 1000mg/500mg Injection
Managing bacterial illnesses
Major Benefits of Megmazid SB 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Megmazid SB 1000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Megmazid SB 1000mg/500mg Injection:
Administering this medication will be done by your physician or their associate; self-medication is strictly prohibited.
How Megmazid SB 1000mg/500mg Injection works:
Ceftazidime/Sulbactam 1000mg/500mg (Megmazid SB Injection) combines a cephalosporin antibiotic (Ceftazidime) with a beta-lactamase inhibitor (Sulbactam). Ceftazidime disrupts bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counters bacterial resistance mechanisms, boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Megmazid SB 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Megmazid SB (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Megmazid SB 1000mg/500mg Injection is considered safe for use while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingUNSAFE
The administration of Megmazid SB 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCAUTION
For individuals with impaired kidney function, administration of Megmazid SB 1000mg/500mg Injection requires careful consideration. Dosage modification of Megmazid SB 1000mg/500mg Injection may be necessary. A physician's consultation is recommended.
LiverCAUTION
Careful administration of Megmazid SB 1000mg/500mg Injection is advised for individuals with advanced hepatic impairment. Dosage modification of Megmazid SB 1000mg/500mg Injection might be necessary. Physician consultation is recommended.
What if you forget to take Megmazid SB 1000mg/500mg Injection :
Omit a dose of Megmazid SB 1000mg/500mg Injection? Seek your physician's advice.
Facts to Know About Megmazid SB 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
